Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/12789
Title: NICE 2011 recommendations on the management of Alzheimer’s disease by acetylcholinesterase inhibitors and memantine
Other Titles: NICE 2011 recommendations on the management of Alzheimer’s disease by acetylcholinesterase inhibitors and memantine
Authors: Scerri, Charles
Keywords: Alzheimer's disease -- Therapy
National Institute for Clinical Excellence
Alzheimer's disease -- Treatment
Issue Date: 2011
Publisher: Medical Portals Ltd.
Citation: Scerri, C. (2011). NICE 2011 recommendations on the management of Alzheimer’s disease by acetylcholinesterase inhibitors & memantine. The Synapse, (4), 13,15
Abstract: The National Institute of Clinical Excellence (NICE) has lately overturned its decision to restrict the use of acetycholinesterase inhibitors and memantine in patients diagnosed with Alzheimer’s disease (AD). It is estimated that such a policy U-turn will offer access to a significant number of individuals who were previously denied these medications. This short article will focus on the latest developments and recommendations by NICE on the use of these pharmacological agents in the managment of AD.
URI: https://www.um.edu.mt/library/oar//handle/123456789/12789
Appears in Collections:Scholarly Works - FacM&SPat
The Synapse, Issue 4
The Synapse, Issue 4

Files in This Item:
File Description SizeFormat 
NICE 2011 recommendations.pdf350.96 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.